Clinical trial
Evaluation of Depression Symptoms and Brain Activity Associated With Response to…
NCT00200902 · University of California, Los Angeles, Other · Completed
Key facts
| NCT number | NCT00200902 |
|---|---|
| Title | Evaluation of Depression Symptoms and Brain Activity Associated With Response to Treatment of Depression |
| Official title | Factors of Treatment Response in Major Depressive Disorder |
| Lead sponsor | University of California, Los Angeles, Other |
| Collaborators | National Center for Complementary and Integrative Health (NCCIH) NIH Eli Lilly and Company Industry Wyeth is now a wholly owned subsidiary of Pfizer |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Depression |
| Intervention type | Behavioral, Drug, Other |
| Interventions | Venlafaxine (Effexor), Duloxetine (Cymbalta), Escitalopram (Lexapro), Placebo, Interpersonal Clinical Interaction (ICI) |
| Enrollment | 88 |
| Start date | Aug 1, 2005 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Sep 20, 2005 |
| Last update posted | Aug 13, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: